For Research Use Only. Not for human use.
Recombinant human EPO is a gold-standard molecule for red blood cell production and tissue protection research. Produced in CHO cells, it is 100% identical in amino-acid sequence, disulfide bonding, and glycosylation pattern to endogenous erythropoietin.
Key Scientific Highlights
- Purity ≥ 99% (HPLC & SDS-PAGE)
- Specific activity ≥ 120,000 IU/mg (WHO International Standard)
- Full 165-aa sequence with 3 N-linked + 1 O-linked glycans
- Full Certificate of Analysis (COA): HPLC, IEF (glycoform), bioactivity (TF-1 proliferation), endotoxin < 0.1 EU/µg
- Manufactured in ISO-compliant facilities
Why Researchers Choose Nationwide Peptides EPO
- Exact sequence & glycosylation as endogenous human erythropoietin
- Highest documented bioactivity (≥ 120,000 IU/mg)
- Full analytical package (IEF + TF-1 assay included)
